Cite
APA Citation
D'Haens, G., Kobayashi, T., Morris, N., Lissoos, T., Hoover, A., Li, X., Arora, V., Milch, C., Sandborn, W. J., & Sands, B. E. (n.d.). oP26 Efficacy and safety of mirikizumab as induction therapy in patients with moderately to severely active Ulcerative Colitis: Results from the Phase 3 LUCENT-1 study. Journal of Crohn's and colitis, 16, i028–i029. http://access.bl.uk/ark:/81055/vdc_100150514992.0x00000b